Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including g...

Full description

Saved in:

Bibliographic Details
Published in:	Molecular neurodegeneration Vol. 12; no. 1; p. 11
Main Authors:	Moors, Tim E., Hoozemans, Jeroen J. M., Ingrassia, Angela, Beccari, Tommaso, Parnetti, Lucilla, Chartier-Harlin, Marie-Christine, van de Berg, Wilma D. J.
Format:	Journal Article
Language:	English
Published:	London BioMed Central 25.01.2017 BioMed Central Ltd Springer Nature B.V
Subjects:	Autophagy (Cytology) Biomedical and Life Sciences Biomedicine Care and treatment Dosage and administration Genetic aspects Health aspects Life Sciences Molecular Medicine Neurology Neurosciences Parkinson's disease Rapamycin Review Risk factors Autophagic Cell Death Dementia With Lewy Body Ambroxol Dementia With Lewy Body Patient Gauche Disease
ISSN:	1750-1326, 1750-1326
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including glucosidase beta acid 1 ( GBA1 ), that are associated with increased risk for developing PD. Observations in PD brain tissue suggest an aberrant regulation of autophagy associated with the aggregation of α-synuclein (α-syn). As autophagy is one of the main systems involved in the proteolytic degradation of α-syn, pharmacological enhancement of autophagy may be an attractive strategy to combat α-syn aggregation in PD. Here, we review the potential of autophagy enhancement as disease-modifying therapy in PD based on preclinical evidence. In particular, we provide an overview of the molecular regulation of autophagy and targets for pharmacological modulation within the ALP. In experimental models, beneficial effects on multiple pathological processes involved in PD, including α-syn aggregation, cell death, oxidative stress and mitochondrial dysfunction, have been demonstrated using the autophagy enhancers rapamycin and lithium. However, selectivity of these agents is limited, while upstream ALP signaling proteins are involved in many other pathways than autophagy. Broad stimulation of autophagy may therefore cause a wide spectrum of dose-dependent side-effects, suggesting that its clinical applicability is limited. However, recently developed agents selectively targeting core ALP components, including Transcription Factor EB (TFEB), lysosomes, GCase as well as chaperone-mediated autophagy regulators, exert more specific effects on molecular pathogenetic processes causing PD. To conclude, the targeted manipulation of downstream ALP components, rather than broad autophagy stimulation, may be an attractive strategy for the development of novel pharmacological therapies in PD. Further characterization of dysfunctional autophagy in different stages and molecular subtypes of PD in combination with the clinical translation of downstream autophagy regulation offers exciting new avenues for future drug development.
AbstractList	Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including glucosidase beta acid 1 ( GBA1 ), that are associated with increased risk for developing PD. Observations in PD brain tissue suggest an aberrant regulation of autophagy associated with the aggregation of α-synuclein (α-syn). As autophagy is one of the main systems involved in the proteolytic degradation of α-syn, pharmacological enhancement of autophagy may be an attractive strategy to combat α-syn aggregation in PD. Here, we review the potential of autophagy enhancement as disease-modifying therapy in PD based on preclinical evidence. In particular, we provide an overview of the molecular regulation of autophagy and targets for pharmacological modulation within the ALP. In experimental models, beneficial effects on multiple pathological processes involved in PD, including α-syn aggregation, cell death, oxidative stress and mitochondrial dysfunction, have been demonstrated using the autophagy enhancers rapamycin and lithium. However, selectivity of these agents is limited, while upstream ALP signaling proteins are involved in many other pathways than autophagy. Broad stimulation of autophagy may therefore cause a wide spectrum of dose-dependent side-effects, suggesting that its clinical applicability is limited. However, recently developed agents selectively targeting core ALP components, including Transcription Factor EB (TFEB), lysosomes, GCase as well as chaperone-mediated autophagy regulators, exert more specific effects on molecular pathogenetic processes causing PD. To conclude, the targeted manipulation of downstream ALP components, rather than broad autophagy stimulation, may be an attractive strategy for the development of novel pharmacological therapies in PD. Further characterization of dysfunctional autophagy in different stages and molecular subtypes of PD in combination with the clinical translation of downstream autophagy regulation offers exciting new avenues for future drug development. Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson's Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including glucosidase beta acid 1 (GBA1), that are associated with increased risk for developing PD. Observations in PD brain tissue suggest an aberrant regulation of autophagy associated with the aggregation of α-synuclein (α-syn). As autophagy is one of the main systems involved in the proteolytic degradation of α-syn, pharmacological enhancement of autophagy may be an attractive strategy to combat α-syn aggregation in PD. Here, we review the potential of autophagy enhancement as disease-modifying therapy in PD based on preclinical evidence. In particular, we provide an overview of the molecular regulation of autophagy and targets for pharmacological modulation within the ALP. In experimental models, beneficial effects on multiple pathological processes involved in PD, including α-syn aggregation, cell death, oxidative stress and mitochondrial dysfunction, have been demonstrated using the autophagy enhancers rapamycin and lithium. However, selectivity of these agents is limited, while upstream ALP signaling proteins are involved in many other pathways than autophagy. Broad stimulation of autophagy may therefore cause a wide spectrum of dose-dependent side-effects, suggesting that its clinical applicability is limited. However, recently developed agents selectively targeting core ALP components, including Transcription Factor EB (TFEB), lysosomes, GCase as well as chaperone-mediated autophagy regulators, exert more specific effects on molecular pathogenetic processes causing PD. To conclude, the targeted manipulation of downstream ALP components, rather than broad autophagy stimulation, may be an attractive strategy for the development of novel pharmacological therapies in PD. Further characterization of dysfunctional autophagy in different stages and molecular subtypes of PD in combination with the clinical translation of downstream autophagy regulation offers exciting new avenues for future drug development. AbstractConverging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including glucosidase beta acid 1 (GBA1), that are associated with increased risk for developing PD. Observations in PD brain tissue suggest an aberrant regulation of autophagy associated with the aggregation of α-synuclein (α-syn). As autophagy is one of the main systems involved in the proteolytic degradation of α-syn, pharmacological enhancement of autophagy may be an attractive strategy to combat α-syn aggregation in PD. Here, we review the potential of autophagy enhancement as disease-modifying therapy in PD based on preclinical evidence. In particular, we provide an overview of the molecular regulation of autophagy and targets for pharmacological modulation within the ALP. In experimental models, beneficial effects on multiple pathological processes involved in PD, including α-syn aggregation, cell death, oxidative stress and mitochondrial dysfunction, have been demonstrated using the autophagy enhancers rapamycin and lithium. However, selectivity of these agents is limited, while upstream ALP signaling proteins are involved in many other pathways than autophagy. Broad stimulation of autophagy may therefore cause a wide spectrum of dose-dependent side-effects, suggesting that its clinical applicability is limited. However, recently developed agents selectively targeting core ALP components, including Transcription Factor EB (TFEB), lysosomes, GCase as well as chaperone-mediated autophagy regulators, exert more specific effects on molecular pathogenetic processes causing PD. To conclude, the targeted manipulation of downstream ALP components, rather than broad autophagy stimulation, may be an attractive strategy for the development of novel pharmacological therapies in PD. Further characterization of dysfunctional autophagy in different stages and molecular subtypes of PD in combination with the clinical translation of downstream autophagy regulation offers exciting new avenues for future drug development.
ArticleNumber	11
Audience	Academic
Author	Hoozemans, Jeroen J. M. van de Berg, Wilma D. J. Moors, Tim E. Parnetti, Lucilla Ingrassia, Angela Chartier-Harlin, Marie-Christine Beccari, Tommaso
Author_xml	– sequence: 1 givenname: Tim E. orcidid: 0000-0003-2223-9947 surname: Moors fullname: Moors, Tim E. email: t.moors@vumc.nl organization: Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam Neuroscience, VU University Medical Center Amsterdam – sequence: 2 givenname: Jeroen J. M. surname: Hoozemans fullname: Hoozemans, Jeroen J. M. organization: Department of Pathology, Amsterdam Neuroscience, VU University Medical Center Amsterdam – sequence: 3 givenname: Angela surname: Ingrassia fullname: Ingrassia, Angela organization: Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam Neuroscience, VU University Medical Center Amsterdam – sequence: 4 givenname: Tommaso surname: Beccari fullname: Beccari, Tommaso organization: Department of Pharmaceutical Sciences, University of Perugia – sequence: 5 givenname: Lucilla surname: Parnetti fullname: Parnetti, Lucilla organization: Department of Medicine, Section of Neurology, University of Perugia – sequence: 6 givenname: Marie-Christine surname: Chartier-Harlin fullname: Chartier-Harlin, Marie-Christine organization: UMR-S 1172—JPArc—Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, University of Lille, Inserm, UMR-S 1172, Team “Early stages of Parkinson’s disease” – sequence: 7 givenname: Wilma D. J. surname: van de Berg fullname: van de Berg, Wilma D. J. organization: Department of Anatomy and Neurosciences, Section Clinical Neuroanatomy, Amsterdam Neuroscience, VU University Medical Center Amsterdam
BackLink	https://inserm.hal.science/inserm-01446327$$DView record in HAL
BookMark	eNp9kc1u1DAUhS1URH_gAdhFYsOiKdc_iZ3lqKIUaSRYzN66k7nJuGTswU6QuuM1eD2eBEdBUCpAlmXL_o7vPT7n7MQHT4y95HDFuanfJC5BqBK4zrNSpXzCzriuoORS1CcP9qfsPKU7AKUBqmfsVBieRSDO2Hqzp4hHmkbXFscwkh8dDkXoCpzGcNxjf1-S36Nvne8L7PN9KpwvPmL85HwK_vvXb6nYuUSY6Dl72uGQ6MXP9YJtbt5urm_L9Yd3769X67JVWstSIm45Gb3tchtbXQu-q2oko7aikbuKJDQGOl6jghYUUi3qqjKyUSBVB5W8YJfLs3sc7DG6A8Z7G9DZ29Xa5qYoHixwpWop9Bee8dcLfozh80RptAeXWhoG9BSmZPNPCmFkxjP66hF6F6bos5eZqjg0jTG_qR4HygW7MEZs50ftShmooRFcZ-rqL1QeOzq4NgfZuXz-h4AvgjaGlCJ1v7xxsHPedsk7e9N2ztvODetHmtaNOLrgczE3_FcpFmXKVXxP8YHVf4p-AIagu9k
CitedBy_id	crossref_primary_10_4103_1673_5374_324830 crossref_primary_10_1007_s11064_018_2617_5 crossref_primary_10_1016_j_neuroscience_2022_07_007 crossref_primary_10_3389_fnins_2019_01352 crossref_primary_10_3390_ijms20030719 crossref_primary_10_1016_j_ejphar_2019_172677 crossref_primary_10_3390_brainsci13040670 crossref_primary_10_1016_j_neuint_2022_105297 crossref_primary_10_3389_fnagi_2020_630743 crossref_primary_10_3390_brainsci12101308 crossref_primary_10_1073_pnas_2203824119 crossref_primary_10_1111_jnc_15130 crossref_primary_10_1134_S0006297924070113 crossref_primary_10_3389_fnins_2018_00693 crossref_primary_10_1134_S1819712423040190 crossref_primary_10_3389_fnins_2021_746873 crossref_primary_10_3390_antiox12020485 crossref_primary_10_1073_pnas_2103425118 crossref_primary_10_1016_j_neuint_2017_12_014 crossref_primary_10_1007_s10517_021_05242_z crossref_primary_10_1007_s12264_021_00711_x crossref_primary_10_1016_j_neulet_2018_05_009 crossref_primary_10_3389_fphys_2022_1015500 crossref_primary_10_1016_j_bbapap_2019_03_001 crossref_primary_10_1096_fj_201901712R crossref_primary_10_3892_mmr_2019_10152 crossref_primary_10_1021_acschemneuro_5c00087 crossref_primary_10_1038_s41419_023_06154_8 crossref_primary_10_3390_ijms23169364 crossref_primary_10_1016_j_jid_2023_09_276 crossref_primary_10_3390_ijms21218376 crossref_primary_10_3389_fneur_2020_00556 crossref_primary_10_3389_fnins_2021_745815 crossref_primary_10_3390_ijms222212263 crossref_primary_10_1097_WCO_0000000000000579 crossref_primary_10_1186_s13041_019_0439_2 crossref_primary_10_1038_s41420_024_01848_0 crossref_primary_10_1016_j_arr_2017_09_006 crossref_primary_10_1016_j_neubiorev_2023_105148 crossref_primary_10_1111_ene_14108 crossref_primary_10_3390_cells10113022 crossref_primary_10_1186_s40035_017_0104_6 crossref_primary_10_3389_fcell_2021_666675 crossref_primary_10_1038_s41419_020_2322_6 crossref_primary_10_1155_2022_2877728 crossref_primary_10_1515_dmdi_2021_0128 crossref_primary_10_3389_fnins_2021_777347 crossref_primary_10_1042_BCJ20190616 crossref_primary_10_1002_tox_22854 crossref_primary_10_1007_s12640_018_9917_z crossref_primary_10_1016_j_chemosphere_2019_125336 crossref_primary_10_3390_ijms22020710 crossref_primary_10_1016_j_nbd_2019_104587 crossref_primary_10_1371_journal_pgen_1011518 crossref_primary_10_1016_j_cca_2019_03_1627 crossref_primary_10_1007_s00210_023_02627_x crossref_primary_10_1098_rsob_170271 crossref_primary_10_1161_CIRCRESAHA_125_326129 crossref_primary_10_1155_2020_8865611 crossref_primary_10_2174_1381612829666221102151926 crossref_primary_10_3389_fnagi_2021_691881 crossref_primary_10_1007_s00109_024_02512_x crossref_primary_10_1016_j_biopha_2020_110968 crossref_primary_10_3389_fimmu_2023_1273570 crossref_primary_10_1007_s12035_018_1090_0 crossref_primary_10_3389_fncel_2021_654340 crossref_primary_10_1177_1877718X251359391 crossref_primary_10_3390_bioengineering10070871 crossref_primary_10_3390_brainsci13081124 crossref_primary_10_1016_j_pneurobio_2018_09_003 crossref_primary_10_3389_fnins_2019_00457 crossref_primary_10_3892_etm_2018_5999 crossref_primary_10_3389_fnmol_2018_00144 crossref_primary_10_1016_j_pbb_2025_173966 crossref_primary_10_3389_fcell_2021_761773 crossref_primary_10_1016_j_abb_2023_109672 crossref_primary_10_4103_1673_5374_390954 crossref_primary_10_1016_j_pbb_2018_12_005 crossref_primary_10_3389_fcell_2021_683459 crossref_primary_10_1016_j_pneurobio_2022_102298 crossref_primary_10_3390_antiox11010076 crossref_primary_10_1016_j_neuint_2020_104756 crossref_primary_10_3389_fnagi_2018_00395 crossref_primary_10_1097_TP_0000000000001999 crossref_primary_10_1016_j_fct_2020_111626 crossref_primary_10_3390_biom13050816 crossref_primary_10_1016_j_neuropharm_2024_110180 crossref_primary_10_1002_dneu_22534 crossref_primary_10_1523_JNEUROSCI_1579_24_2025 crossref_primary_10_1007_s11064_020_03061_8 crossref_primary_10_4103_1673_5374_371345 crossref_primary_10_1016_j_expneurol_2021_113598 crossref_primary_10_1016_j_mocell_2024_100173 crossref_primary_10_3390_antiox13060715 crossref_primary_10_1016_j_arr_2024_102577 crossref_primary_10_1038_s41419_024_06540_w crossref_primary_10_1155_2022_1837278 crossref_primary_10_1080_1028415X_2020_1859729 crossref_primary_10_1177_17590914211028364 crossref_primary_10_1155_2020_5497046 crossref_primary_10_1016_j_jmb_2020_02_023 crossref_primary_10_4103_1673_5374_313053 crossref_primary_10_3389_fnagi_2020_00226 crossref_primary_10_3390_cells7050037 crossref_primary_10_1016_j_neuropharm_2024_109909 crossref_primary_10_1016_j_neuroscience_2023_01_024 crossref_primary_10_1139_cjpp_2021_0013 crossref_primary_10_1002_mds_29688 crossref_primary_10_1124_pharmrev_120_000133 crossref_primary_10_3389_fnagi_2020_00100 crossref_primary_10_3390_biom13101435 crossref_primary_10_1016_j_brainres_2021_147749 crossref_primary_10_3390_cells10081850 crossref_primary_10_3390_ijms25073899 crossref_primary_10_1016_j_lfs_2025_123789 crossref_primary_10_1177_1073858418811787 crossref_primary_10_1038_s41582_024_01043_w crossref_primary_10_1186_s13024_025_00856_7 crossref_primary_10_3389_fnmol_2019_00271 crossref_primary_10_1039_C9FO02288K crossref_primary_10_3390_jcm11061749 crossref_primary_10_1016_j_neuint_2022_105380 crossref_primary_10_1038_s41420_019_0210_6 crossref_primary_10_1038_s41419_021_03742_4 crossref_primary_10_3390_cells11071205 crossref_primary_10_1038_s41419_018_0909_y crossref_primary_10_3389_fnins_2020_602697 crossref_primary_10_1016_j_mam_2021_101018 crossref_primary_10_1016_j_arr_2024_102327 crossref_primary_10_4103_1673_5374_280324 crossref_primary_10_1016_j_jep_2021_114347 crossref_primary_10_1042_BST20170121 crossref_primary_10_1007_s12035_018_1340_1 crossref_primary_10_3389_fnagi_2019_00049 crossref_primary_10_3390_antiox14050554 crossref_primary_10_1186_s12929_023_00961_z crossref_primary_10_1016_j_jnutbio_2018_10_015 crossref_primary_10_1002_mds_27895 crossref_primary_10_3389_fncel_2021_644507 crossref_primary_10_3390_ijms19082325 crossref_primary_10_7759_cureus_35458 crossref_primary_10_3389_fnmol_2023_1168948 crossref_primary_10_3389_fnagi_2018_00370 crossref_primary_10_3389_fnagi_2023_1130658 crossref_primary_10_1016_j_phrs_2020_105361 crossref_primary_10_3389_fnins_2020_00577 crossref_primary_10_1007_s11064_024_04130_y crossref_primary_10_1016_j_arr_2023_101907 crossref_primary_10_3390_cells10123547 crossref_primary_10_1007_s00401_024_02707_z crossref_primary_10_1038_nrd_2018_136 crossref_primary_10_3390_nu14173508 crossref_primary_10_1111_jnc_16043 crossref_primary_10_1002_1873_3468_13464 crossref_primary_10_1016_j_bioadv_2022_212876 crossref_primary_10_1016_j_lfs_2024_123088 crossref_primary_10_1038_s41531_022_00282_2 crossref_primary_10_3390_cells8070712 crossref_primary_10_3390_molecules26237340 crossref_primary_10_1002_med_21662 crossref_primary_10_1155_2021_7093844 crossref_primary_10_1186_s13619_025_00224_2 crossref_primary_10_1016_j_jbc_2022_102260 crossref_primary_10_3390_metabo13030416 crossref_primary_10_3390_ijms20030728 crossref_primary_10_1016_j_neures_2019_12_017 crossref_primary_10_1093_jb_mvac051 crossref_primary_10_1515_nf_2018_0029 crossref_primary_10_3390_cells8040364 crossref_primary_10_3390_ijms23126808 crossref_primary_10_1016_j_neuint_2020_104671 crossref_primary_10_1002_jcb_28654 crossref_primary_10_1016_j_ejphar_2024_176823 crossref_primary_10_12688_f1000research_11820_1 crossref_primary_10_3390_biomedicines12081777 crossref_primary_10_3390_biomedicines12030552 crossref_primary_10_1016_j_fitote_2024_105883 crossref_primary_10_1016_j_mcn_2022_103751 crossref_primary_10_1155_2022_3723567 crossref_primary_10_3390_cells8010059 crossref_primary_10_3389_fnmol_2023_1230436
Cites_doi	10.1002/mds.25495 10.1212/WNL.0000000000000004 10.1038/emboj.2012.32 10.1523/JNEUROSCI.0499-12.2012 10.1038/cdd.2014.143 10.1038/ncomms5755 10.1093/hmg/ddr606 10.1016/j.neuroscience.2009.08.014 10.1016/j.bbrc.2015.08.076 10.1007/s00018-011-0865-5 10.1038/nrneurol.2013.132 10.1038/nn.3489 10.1021/jm300063b 10.1371/journal.pone.0163029 10.1111/bpa.12267 10.1016/j.braindev.2012.05.008 10.1126/science.1204592 10.1016/j.nbd.2013.11.002 10.1016/j.chembiol.2014.09.019 10.1007/s12035-012-8341-2 10.1021/cn5000309 10.1038/nrm.2016.74 10.1016/j.tcb.2015.08.010 10.1038/nchembio.1230 10.1016/j.neuro.2015.03.009 10.1038/ncb847 10.1074/jbc.M113.457408 10.1016/j.nbd.2011.05.022 10.1038/nrn3068 10.1016/j.ejphar.2014.06.042 10.1016/j.cell.2012.03.017 10.1007/s12035-015-9124-3 10.1038/nature04724 10.1016/j.cell.2007.10.018 10.1073/pnas.1405700111 10.1016/j.neurobiolaging.2013.06.010 10.1126/scitranslmed.3008659 10.1073/pnas.1305623110 10.3389/fnins.2015.00403 10.1007/s11481-012-9431-7 10.1111/j.1471-4159.2009.06463 10.1159/000328516 10.1074/jbc.M609532200 10.1091/mbc.E08-01-0080 10.1074/jbc.M300227200 10.1186/s13000-016-0459-5 10.1074/jbc.M801992200 10.1186/s12868-015-0222-y 10.1007/s13311-014-0294-x 10.1126/scisignal.aac5472 10.1073/pnas 10.4161/15384101.2014.973309 10.1016/j.neuint.2011.01.008 10.1073/pnas.1300822110 10.1523/JNEUROSCI.5519-10.2011 10.1152/physrev.00030.2009 10.1002/mds.25772 10.1523/JNEUROSCI.4390-09.2009 10.1016/j.bbadis.2014.02.010 10.1111/jnc.13696 10.1371/journal.pone.0128651 10.1016/j.neuroscience.2014.11.004 10.1074/jbc.M111.280016 10.1146/annurev-biochem-060815-014556 10.1523/JNEUROSCI.0636-16.2016 10.1101/gad.287524.116 10.1523/JNEUROSCI.21-24-09549.2001 10.1074/jbc.M113.506246 10.1016/j.nbd.2015.09.009 10.1212/WNL.0b013e31828f180e 10.1073/pnas.95.11.6469 10.1126/science.1174447 10.2353/ajpath.2009.080928 10.1039/b804606a 10.1093/brain/awt367 10.1016/j.cell.2011.06.001 10.1016/j.neuro.2009.06.009 10.1038/ncb2152 10.1074/jbc.M110.132514 10.1038/sj.cdd.4402099 10.1371/journal.pone.0049635 10.1016/j.nbd.2014.04.003 10.4161/auto.7.5.14811 10.1007/s12035-014-8933-0 10.1080/15548627.2015.1067364 10.1016/j.parkreldis.2015.06.016 10.1126/science.1207056 10.1016/j.nbd.2015.06.008 10.1111/jnc.13517 10.1016/0022-510X(95)00035-Z 10.1002/jnr.10663 10.1038/cddis.2014.175 10.1016/j.molmed.2012.11.001 10.1002/ana.23614 10.1016/j.biocel.2016.08.019 10.1093/hmg/ddt674 10.1016/j.neuroscience.2014.07.046 10.1073/pnas.1108197108 10.1186/s13024-015-0010-2 10.1002/mds.26562 10.1073/pnas.1309991110 10.1016/S0304-3940(01)01966-8 10.1371/journal.pone.0120819 10.1111/j.1527-3458.2007.00032.x 10.3109/00207454.2012.729234 10.1523/JNEUROSCI.3944-09.2010 10.1093/brain/awu020 10.1111/j.1742-4658.2010.07588.x 10.1093/hmg/ddu585 10.1126/science.1101738 10.1093/brain/awu002 10.1111/bpa.12297 10.1038/nn.2372 10.3233/JPD-120155 10.1038/cddis.2015.283 10.1002/ajmg.b.32214 10.1073/pnas.0605928103 10.1128/MCB.06159-11 10.1101/cshperspect.a009357 10.1002/mds.26477 10.1038/nature04723 10.3233/JAD-2012-120178 10.1155/2012/219625 10.1523/JNEUROSCI.1920-10.2010 10.1007/s00401-011-0828-9 10.1083/jcb.200504035 10.1093/hmg/ddt192 10.1242/jcs.115865 10.1038/nm.3232 10.1038/nchembio.79 10.1038/nchembio883 10.1038/tp.2013.97 10.1016/j.neuro.2014.07.006 10.1002/mds.21399 10.1038/nrc3262 10.1038/nn.3350 10.1073/pnas.1220464110 10.1111/j.1471-4159.2008.05217 10.1371/journal.pone.0009313 10.1371/journal.pgen.1004302 10.3402/pba.v5.28743 10.1001/archneurol.2010.198 10.1016/j.neuroscience.2011.10.031 10.1080/15548627.2015.1136769 10.1007/s12264-015-1528-y 10.1016/j.neuroscience.2014.04.039 10.1016/j.neurobiolaging.2010.05.021 10.1002/mds.26141 10.1038/nrd3802 10.4161/auto.8.1.18313 10.1126/scisignal.2000308 10.1038/cddis.2013.73 10.1371/journal.pone.0005515 10.1007/s12035-015-9173-7 10.1016/j.nbd.2013.11.007 10.1007/s11064-012-0823-0 10.1016/j.mcn.2015.03.013 10.1016/j.nbd.2009.05.023 10.1093/brain/awt131 10.1016/j.cellsig.2014.04.009 10.1007/s00401-012-1004-6 10.1038/mp.2012.115 10.1002/ana.24011 10.1186/2051-5960-1-11 10.1111/j.1460-9568.2007.05914.x 10.1179/1743132813Y.0000000224 10.3390/ijms15011625 10.1056/NEJMra1205406 10.1056/NEJMoa0901281 10.1016/j.tcb.2003.12.002
ContentType	Journal Article
Copyright	The Author(s). 2017 COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml	– notice: The Author(s). 2017 – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 – notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID	C6C AAYXX CITATION 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC VOOES
DOI	10.1186/s13024-017-0154-3
DatabaseName	Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Proquest Central ProQuest One Community College ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access)
DatabaseTitle	CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic
Database_xml	– sequence: 1 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Anatomy & Physiology
EISSN	1750-1326
EndPage	11
ExternalDocumentID	oai:HAL:inserm-01446327v1 4312170641 A480609217 10_1186_s13024_017_0154_3
GrantInformation_xml	– fundername: Ligue Europeénne contre la Maladie d'Alzheimer – fundername: Association France Parkinson grantid: 2015, R16008EE funderid: http://dx.doi.org/10.13039/501100008211 – fundername: ZonMw Memorabel – fundername: Internationale Stichting Alzheimer Onderzoek (ISAO) – fundername: Roche Innovation Center – fundername: Ministère des affaires sociales et de la santé/CHR grantid: PHRC park de novo, and Bonus H, 2014 – fundername: Michael J. Fox Foundation for Parkinson's Research grantid: ID 10609, ID 5244, ID 011215 funderid: http://dx.doi.org/10.13039/100000864 – fundername: University of Lille-CNRS and Region Hauts de France grantid: PEPS 2016 – fundername: LECMA grantid: RD1507
GroupedDBID	--- 0R~ 123 29M 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABIVO ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HH5 HMCUK HYE IAO IHR INH INR IPY ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW ~8M AAYXX AFFHD CITATION 3V. 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 1XC 2VQ 4.4 IPNFZ LGEZI LOTEE NADUK NXXTH RIG VOOES
ID	FETCH-LOGICAL-c4773-3aab1e87bf810b7621d56ae84b293d5e30980f16a40c04ae626558394034f053
IEDL.DBID	7X7
ISSN	1750-1326
IngestDate	Tue Oct 14 20:39:10 EDT 2025 Fri Sep 05 06:35:37 EDT 2025 Sun Oct 19 01:23:15 EDT 2025 Tue Nov 11 10:38:06 EST 2025 Tue Nov 04 17:28:51 EST 2025 Sat Nov 29 03:16:34 EST 2025 Tue Nov 18 21:18:21 EST 2025 Sat Sep 06 07:29:29 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Autophagic Cell Death Dementia With Lewy Body Ambroxol Dementia With Lewy Body Patient Gauche Disease
Language	English
License	Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4773-3aab1e87bf810b7621d56ae84b293d5e30980f16a40c04ae626558394034f053
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ORCID	0000-0003-2223-9947
OpenAccessLink	https://www.proquest.com/docview/1865109988?pq-origsite=%requestingapplication%
PMID	28101702
PQID	1865109988
PQPubID	55149
PageCount	1
ParticipantIDs	hal_primary_oai_HAL_inserm_01446327v1 proquest_miscellaneous_1862283463 proquest_journals_1865109988 gale_infotracmisc_A480609217 gale_infotracacademiconefile_A480609217 crossref_primary_10_1186_s13024_017_0154_3 crossref_citationtrail_10_1186_s13024_017_0154_3 springer_journals_10_1186_s13024_017_0154_3
PublicationCentury	2000
PublicationDate	20170125
PublicationDateYYYYMMDD	2017-01-25
PublicationDate_xml	– month: 1 year: 2017 text: 20170125 day: 25
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London
PublicationTitle	Molecular neurodegeneration
PublicationTitleAbbrev	Mol Neurodegeneration
PublicationYear	2017
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V
References	AB Manning-Bog (154_CR77) 2009; 30 JH Lu (154_CR141) 2012; 8 AM Choi (154_CR23) 2013; 368 M Elstner (154_CR66) 2011; 122 E White (154_CR126) 2012; 12 JW Steele (154_CR115) 2013; 18 JC Farré (154_CR16) 2016; 17 ME Gegg (154_CR55) 2012; 72 A Khaminets (154_CR17) 2016; 26 VS Burchell (154_CR44) 2013; 16 M Dulovic (154_CR97) 2014; 63 M Xilouri (154_CR5) 2016; 31 E Mutez (154_CR67) 2014; 63 AG Jegga (154_CR167) 2011; 7 WH Yu (154_CR72) 2009; 175 L Alvarez-Erviti (154_CR170) 2013; 4 M Xilouri (154_CR133) 2009; 4 E Dagan (154_CR39) 2015; 21 B Ravikumar (154_CR13) 2010; 90 AM Cuervo (154_CR73) 2004; 305 A Ferretta (154_CR102) 2014; 1842 S Patnaik (154_CR160) 2012; 55 D Toulorge (154_CR49) 2016; 139 S Alers (154_CR24) 2012; 32 TK Lin (154_CR101) 2014; 15 D Chiasserini (154_CR57) 2015; 10 ML Hebron (154_CR122) 2013; 22 AH Schapira (154_CR148) 2013; 110 T Hara (154_CR6) 2006; 441 M Rothaug (154_CR61) 2014; 111 LS Tain (154_CR87) 2009; 12 KC Choi (154_CR129) 2010; 112 K Kilpatrick (154_CR143) 2015; 10 C Yang (154_CR158) 2013; 110 KE Murphy (154_CR63) 2013; 1 Z Gan-Or (154_CR41) 2013; 80 154_CR81 B Spencer (154_CR137) 2009; 29 E Sidransky (154_CR32) 2012; 11 PR Bharadwaj (154_CR116) 2013; 3 RM Wu (154_CR42) 2014; 82 C Gomez-Santos (154_CR127) 2003; 73 HC Cheng (154_CR131) 2011; 31 WW Li (154_CR12) 2012; 69 SP Sardi (154_CR78) 2011; 108 AH Schapira (154_CR36) 2015; 66 A Oueslati (154_CR74) 2013; 110 Y Chu (154_CR52) 2009; 35 E Sidransky (154_CR33) 2009; 361 D Reczek (154_CR38) 2007; 131 Y Miki (154_CR69) 2015; 26 CA Lazzara (154_CR90) 2015; 9 D Ramonet (154_CR64) 2012; 21 DA East (154_CR165) 2016; 79 S Sarkar (154_CR104) 2007; 282 F Richter (154_CR159) 2014; 11 S Sarkar (154_CR112) 2007; 3 L Alvarez-Erviti (154_CR53) 2010; 67 C Balducci (154_CR58) 2007; 22 154_CR149 L Crews (154_CR68) 2010; 5 BJ Bosch De (154_CR103) 2016; 9 R Zoncu (154_CR28) 2011; 334 MA Lynch-Day (154_CR9) 2012; 2 MH Savolainen (154_CR140) 2014; 68 X Gao (154_CR21) 2002; 4 EM Rocha (154_CR147) 2015; 82 Y Wu (154_CR100) 2011; 19 G Ambrosi (154_CR151) 2015; 82 Q He (154_CR109) 2015; 53 L Hou (154_CR92) 2015; 16 EJ Bae (154_CR80) 2014; 5 DA East (154_CR166) 2014; 21 H Wu (154_CR171) 2014; 52 S Sarkar (154_CR113) 2008; 4 OV Forlenza (154_CR89) 2014; 5 J Bove (154_CR10) 2011; 12 T Vogiatzi (154_CR71) 2008; 283 S Tenreiro (154_CR75) 2014; 10 X Bai (154_CR84) 2015; 5 M Decressac (154_CR70) 2013; 110 C Settembre (154_CR27) 2012; 31 G Filomeni (154_CR120) 2012; 33 T Pan (154_CR82) 2009; 164 154_CR132 J Liu (154_CR34) 2014; 165B C Settembre (154_CR26) 2011; 332 MS Ur Rasheed (154_CR99) 2015; 53 PR Bharadwaj (154_CR114) 2012; 32 M Decressac (154_CR86) 2013; 3 A Mcneill (154_CR150) 2014; 137 L Stefanis (154_CR128) 2001; 21 T Weiser (154_CR153) 2008; 14 TF Jiang (154_CR119) 2013; 8 XZ Li (154_CR94) 2013; 123 T Obata (154_CR139) 2001; 308 ED Plowey (154_CR47) 2008; 105 D Mantle (154_CR62) 1995; 131 Y Sun (154_CR157) 2012; 287 N Xiong (154_CR93) 2011; 199 K Tanji (154_CR110) 2015; 465 Z Luan (154_CR154) 2013; 35 P Anglade (154_CR48) 1997; 12 E Aflaki (154_CR161) 2014; 6 B Dehay (154_CR50) 2010; 30 M Sardiello (154_CR25) 2009; 325 KE Murphy (154_CR56) 2014; 137 CH Ng (154_CR95) 2012; 32 F Wu (154_CR107) 2015; 284 CF Bento (154_CR18) 2016; 85 J Kim (154_CR20) 2011; 13 S Buttner (154_CR118) 2014; 13 H Wang (154_CR169) 2016; 26 GC Lee (154_CR111) 2015; 48 W Song (154_CR142) 2014; 289 S Park (154_CR46) 2016; 11 AM Cuervo (154_CR14) 2004; 14 MJ Casarejos (154_CR105) 2011; 58 SJ Orenstein (154_CR45) 2013; 16 DM Lan (154_CR106) 2012; 37 M Bourdenx (154_CR145) 2016; 12 J Anguiano (154_CR164) 2013; 9 JL Webb (154_CR4) 2003; 278 BI Perez-Revuelta (154_CR98) 2014; 5 AL Mahul-Mellier (154_CR123) 2014; 23 SP Patil (154_CR96) 2014; 26 GC Baltazar (154_CR144) 2012; 7 C Malagelada (154_CR83) 2010; 30 154_CR37 JN Foo (154_CR40) 2013; 34 Y Liu (154_CR135) 2015; 22 RA Nixon (154_CR8) 2013; 19 AD Rubinstein (154_CR124) 2012; 125 MG Spillantini (154_CR1) 1998; 95 K Tanji (154_CR51) 2011; 43 N Kanagaraj (154_CR168) 2014; 272 E Aflaki (154_CR162) 2016; 36 J Trinh (154_CR43) 2013; 9 JR Mazzulli (154_CR76) 2011; 146 X Mao (154_CR35) 2013; 35 V Choubey (154_CR134) 2011; 286 A Williams (154_CR29) 2008; 4 SA Tanik (154_CR172) 2013; 288 M Xilouri (154_CR2) 2013; 47 EJ Bae (154_CR79) 2015; 6 D Ebrahimi-Fakhari (154_CR3) 2012; 124 K Wang (154_CR138) 2016; 11 E Itakura (154_CR22) 2008; 19 R Amaravadi (154_CR125) 2016; 30 M Komatsu (154_CR7) 2006; 441 KD Dijk van (154_CR59) 2013; 28 R Oruch (154_CR91) 2014; 740C S Sarkar (154_CR108) 2014; 44C Y Xu (154_CR130) 2014; 26 RA Steet (154_CR156) 2006; 103 DC Rubinsztein (154_CR11) 2012; 11 M Laplante (154_CR19) 2012; 149 AA Dijkstra (154_CR65) 2015; 10 M Xilouri (154_CR163) 2013; 136 L Parnetti (154_CR60) 2014; 29 S Sarkar (154_CR88) 2005; 170 KE Murphy (154_CR54) 2015; 30 SP Sardi (154_CR146) 2013; 110 R Khanna (154_CR155) 2010; 277 F Reggiori (154_CR15) 2012; 2012 M Siebert (154_CR152) 2014; 137 D Macedo (154_CR121) 2015; 24 A Criollo (154_CR30) 2007; 14 Z Gan-Or (154_CR31) 2015; 11 CW Olanow (154_CR117) 2013; 74 E Santini (154_CR85) 2009; 2 RW Button (154_CR136) 2015; 31
References_xml	– volume: 28 start-page: 747 year: 2013 ident: 154_CR59 publication-title: Mov Disord doi: 10.1002/mds.25495 – volume: 82 start-page: 283 year: 2014 ident: 154_CR42 publication-title: Neurology doi: 10.1212/WNL.0000000000000004 – volume: 31 start-page: 1095 year: 2012 ident: 154_CR27 publication-title: EMBO J doi: 10.1038/emboj.2012.32 – volume: 32 start-page: 14311 year: 2012 ident: 154_CR95 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0499-12.2012 – volume: 22 start-page: 367 year: 2015 ident: 154_CR135 publication-title: Cell Death Differ doi: 10.1038/cdd.2014.143 – volume: 5 start-page: 4755 year: 2014 ident: 154_CR80 publication-title: Nat Commun doi: 10.1038/ncomms5755 – volume: 21 start-page: 1725 year: 2012 ident: 154_CR64 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddr606 – volume: 164 start-page: 541 year: 2009 ident: 154_CR82 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.08.014 – volume: 465 start-page: 746 year: 2015 ident: 154_CR110 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2015.08.076 – volume: 69 start-page: 1125 year: 2012 ident: 154_CR12 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-011-0865-5 – volume: 9 start-page: 445 year: 2013 ident: 154_CR43 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2013.132 – volume: 16 start-page: 1257 year: 2013 ident: 154_CR44 publication-title: Nat Neurosci doi: 10.1038/nn.3489 – volume: 55 start-page: 5734 year: 2012 ident: 154_CR160 publication-title: J Med Chem doi: 10.1021/jm300063b – volume: 11 start-page: e0163029 year: 2016 ident: 154_CR46 publication-title: Plos One doi: 10.1371/journal.pone.0163029 – volume: 26 start-page: 167 year: 2016 ident: 154_CR169 publication-title: Brain Pathol doi: 10.1111/bpa.12267 – volume: 35 start-page: 317 year: 2013 ident: 154_CR154 publication-title: Brain Dev doi: 10.1016/j.braindev.2012.05.008 – volume: 332 start-page: 1429 year: 2011 ident: 154_CR26 publication-title: Science doi: 10.1126/science.1204592 – volume: 63 start-page: 1 year: 2014 ident: 154_CR97 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2013.11.002 – volume: 21 start-page: 1585 year: 2014 ident: 154_CR166 publication-title: Chem Biol doi: 10.1016/j.chembiol.2014.09.019 – volume: 47 start-page: 537 year: 2013 ident: 154_CR2 publication-title: Mol Neurobiol doi: 10.1007/s12035-012-8341-2 – volume: 5 start-page: 443 year: 2014 ident: 154_CR89 publication-title: ACS Chem Neurosci doi: 10.1021/cn5000309 – volume: 17 start-page: 537 issue: 9 year: 2016 ident: 154_CR16 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2016.74 – volume: 26 start-page: 6 issue: 1 year: 2016 ident: 154_CR17 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2015.08.010 – volume: 9 start-page: 374 year: 2013 ident: 154_CR164 publication-title: Nat Chem Biol doi: 10.1038/nchembio.1230 – volume: 48 start-page: 120 year: 2015 ident: 154_CR111 publication-title: Neurotoxicology doi: 10.1016/j.neuro.2015.03.009 – volume: 4 start-page: 699 year: 2002 ident: 154_CR21 publication-title: Nat Cell Biol doi: 10.1038/ncb847 – volume: 288 start-page: 15194 year: 2013 ident: 154_CR172 publication-title: J Biol Chem doi: 10.1074/jbc.M113.457408 – volume: 43 start-page: 690 year: 2011 ident: 154_CR51 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2011.05.022 – volume: 12 start-page: 437 year: 2011 ident: 154_CR10 publication-title: Nat Rev Neurosci doi: 10.1038/nrn3068 – volume: 740C start-page: 464 year: 2014 ident: 154_CR91 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2014.06.042 – volume: 149 start-page: 274 year: 2012 ident: 154_CR19 publication-title: Cell doi: 10.1016/j.cell.2012.03.017 – volume: 53 start-page: 2751 issue: 5 year: 2015 ident: 154_CR99 publication-title: Mol Neurobiol doi: 10.1007/s12035-015-9124-3 – volume: 441 start-page: 885 year: 2006 ident: 154_CR6 publication-title: Nature doi: 10.1038/nature04724 – volume: 131 start-page: 770 year: 2007 ident: 154_CR38 publication-title: Cell doi: 10.1016/j.cell.2007.10.018 – volume: 111 start-page: 15573 year: 2014 ident: 154_CR61 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1405700111 – volume: 34 start-page: 2890 year: 2013 ident: 154_CR40 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.06.010 – volume: 6 start-page: 240ra year: 2014 ident: 154_CR161 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3008659 – volume: 110 start-page: E1817 year: 2013 ident: 154_CR70 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1305623110 – volume: 9 start-page: 403 year: 2015 ident: 154_CR90 publication-title: Front Neurosci doi: 10.3389/fnins.2015.00403 – volume: 8 start-page: 356 year: 2013 ident: 154_CR119 publication-title: J Neuroimmune Pharmacol doi: 10.1007/s11481-012-9431-7 – volume: 12 start-page: 25 year: 1997 ident: 154_CR48 publication-title: Histol Histopathol – volume: 112 start-page: 366 year: 2010 ident: 154_CR129 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2009.06463 – volume: 19 start-page: 163 year: 2011 ident: 154_CR100 publication-title: Neurosignals doi: 10.1159/000328516 – volume: 282 start-page: 5641 year: 2007 ident: 154_CR104 publication-title: J Biol Chem doi: 10.1074/jbc.M609532200 – volume: 19 start-page: 5360 year: 2008 ident: 154_CR22 publication-title: Mol Biol Cell doi: 10.1091/mbc.E08-01-0080 – volume: 278 start-page: 25009 year: 2003 ident: 154_CR4 publication-title: J Biol Chem doi: 10.1074/jbc.M300227200 – volume: 11 start-page: 15 year: 2016 ident: 154_CR138 publication-title: Diagn Pathol doi: 10.1186/s13000-016-0459-5 – volume: 283 start-page: 23542 year: 2008 ident: 154_CR71 publication-title: J Biol Chem doi: 10.1074/jbc.M801992200 – volume: 16 start-page: 82 year: 2015 ident: 154_CR92 publication-title: BMC Neurosci doi: 10.1186/s12868-015-0222-y – volume: 11 start-page: 840 year: 2014 ident: 154_CR159 publication-title: Neurotherapeutics doi: 10.1007/s13311-014-0294-x – volume: 9 start-page: ra21 year: 2016 ident: 154_CR103 publication-title: Sci Signal doi: 10.1126/scisignal.aac5472 – volume: 110 start-page: 966 year: 2013 ident: 154_CR158 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas – volume: 13 start-page: 3903 year: 2014 ident: 154_CR118 publication-title: Cell Cycle doi: 10.4161/15384101.2014.973309 – volume: 58 start-page: 512 year: 2011 ident: 154_CR105 publication-title: Neurochem Int doi: 10.1016/j.neuint.2011.01.008 – volume: 110 start-page: 3214 year: 2013 ident: 154_CR148 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1300822110 – volume: 31 start-page: 2125 year: 2011 ident: 154_CR131 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5519-10.2011 – volume: 90 start-page: 1383 year: 2010 ident: 154_CR13 publication-title: Physiol Rev doi: 10.1152/physrev.00030.2009 – volume: 29 start-page: 1019 year: 2014 ident: 154_CR60 publication-title: Mov Disord doi: 10.1002/mds.25772 – volume: 29 start-page: 13578 year: 2009 ident: 154_CR137 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4390-09.2009 – volume: 1842 start-page: 902 year: 2014 ident: 154_CR102 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2014.02.010 – volume: 139 start-page: 27 issue: Suppl 1 year: 2016 ident: 154_CR49 publication-title: J Neurochem doi: 10.1111/jnc.13696 – volume: 10 start-page: e0128651 year: 2015 ident: 154_CR65 publication-title: Plos One doi: 10.1371/journal.pone.0128651 – volume: 284 start-page: 900 year: 2015 ident: 154_CR107 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.11.004 – volume: 287 start-page: 4275 year: 2012 ident: 154_CR157 publication-title: J Biol Chem doi: 10.1074/jbc.M111.280016 – volume: 85 start-page: 685 year: 2016 ident: 154_CR18 publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-060815-014556 – volume: 36 start-page: 7441 year: 2016 ident: 154_CR162 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0636-16.2016 – volume: 30 start-page: 1913 year: 2016 ident: 154_CR125 publication-title: Genes Dev doi: 10.1101/gad.287524.116 – volume: 21 start-page: 9549 year: 2001 ident: 154_CR128 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-24-09549.2001 – volume: 289 start-page: 10211 year: 2014 ident: 154_CR142 publication-title: J Biol Chem doi: 10.1074/jbc.M113.506246 – volume: 82 start-page: 495 year: 2015 ident: 154_CR147 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2015.09.009 – volume: 80 start-page: 1606 year: 2013 ident: 154_CR41 publication-title: Neurology doi: 10.1212/WNL.0b013e31828f180e – volume: 95 start-page: 6469 year: 1998 ident: 154_CR1 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.11.6469 – volume: 325 start-page: 473 year: 2009 ident: 154_CR25 publication-title: Science doi: 10.1126/science.1174447 – volume: 175 start-page: 736 year: 2009 ident: 154_CR72 publication-title: Am J Pathol doi: 10.2353/ajpath.2009.080928 – volume: 4 start-page: 895 year: 2008 ident: 154_CR113 publication-title: Mol Biosyst doi: 10.1039/b804606a – volume: 137 start-page: 834 year: 2014 ident: 154_CR56 publication-title: Brain doi: 10.1093/brain/awt367 – volume: 146 start-page: 37 year: 2011 ident: 154_CR76 publication-title: Cell doi: 10.1016/j.cell.2011.06.001 – volume: 30 start-page: 1127 year: 2009 ident: 154_CR77 publication-title: Neurotoxicology doi: 10.1016/j.neuro.2009.06.009 – volume: 13 start-page: 132 year: 2011 ident: 154_CR20 publication-title: Nat Cell Biol doi: 10.1038/ncb2152 – volume: 286 start-page: 10814 year: 2011 ident: 154_CR134 publication-title: J Biol Chem doi: 10.1074/jbc.M110.132514 – volume: 14 start-page: 1029 year: 2007 ident: 154_CR30 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4402099 – volume: 7 start-page: e49635 year: 2012 ident: 154_CR144 publication-title: Plos One doi: 10.1371/journal.pone.0049635 – volume: 68 start-page: 1 year: 2014 ident: 154_CR140 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2014.04.003 – volume: 7 start-page: 477 year: 2011 ident: 154_CR167 publication-title: Autophagy doi: 10.4161/auto.7.5.14811 – volume: 52 start-page: 1284 issue: 3 year: 2014 ident: 154_CR171 publication-title: Mol Neurobiol doi: 10.1007/s12035-014-8933-0 – volume: 11 start-page: 986 year: 2012 ident: 154_CR32 publication-title: Lancet Neurol doi: 10.1080/15548627.2015.1067364 – volume: 21 start-page: 1067 year: 2015 ident: 154_CR39 publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2015.06.016 – volume: 334 start-page: 678 year: 2011 ident: 154_CR28 publication-title: Science doi: 10.1126/science.1207056 – volume: 82 start-page: 235 year: 2015 ident: 154_CR151 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2015.06.008 – ident: 154_CR149 doi: 10.1111/jnc.13517 – volume: 131 start-page: 65 year: 1995 ident: 154_CR62 publication-title: J Neurol Sci doi: 10.1016/0022-510X(95)00035-Z – volume: 73 start-page: 341 year: 2003 ident: 154_CR127 publication-title: J Neurosci Res doi: 10.1002/jnr.10663 – volume: 5 start-page: e1209 year: 2014 ident: 154_CR98 publication-title: Cell Death Dis doi: 10.1038/cddis.2014.175 – ident: 154_CR81 doi: 10.1016/j.molmed.2012.11.001 – volume: 72 start-page: 455 year: 2012 ident: 154_CR55 publication-title: Ann Neurol doi: 10.1002/ana.23614 – volume: 79 start-page: 382 year: 2016 ident: 154_CR165 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2016.08.019 – volume: 11 start-page: 1443 year: 2015 ident: 154_CR31 publication-title: Autophagy doi: 10.1080/15548627.2015.1067364 – volume: 23 start-page: 2858 year: 2014 ident: 154_CR123 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddt674 – volume: 26 start-page: 747 issue: 277 year: 2014 ident: 154_CR96 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.07.046 – volume: 108 start-page: 12101 year: 2011 ident: 154_CR78 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1108197108 – volume: 10 start-page: 15 year: 2015 ident: 154_CR57 publication-title: Mol Neurodegener doi: 10.1186/s13024-015-0010-2 – ident: 154_CR37 doi: 10.1002/mds.26562 – volume: 110 start-page: E3945 year: 2013 ident: 154_CR74 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1309991110 – volume: 308 start-page: 87 year: 2001 ident: 154_CR139 publication-title: Neurosci Lett doi: 10.1016/S0304-3940(01)01966-8 – volume: 10 start-page: e0120819 year: 2015 ident: 154_CR143 publication-title: Plos One doi: 10.1371/journal.pone.0120819 – volume: 14 start-page: 17 year: 2008 ident: 154_CR153 publication-title: CNS Neurosci Ther doi: 10.1111/j.1527-3458.2007.00032.x – volume: 123 start-page: 73 year: 2013 ident: 154_CR94 publication-title: Int J Neurosci doi: 10.3109/00207454.2012.729234 – volume: 30 start-page: 1166 year: 2010 ident: 154_CR83 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3944-09.2010 – volume: 137 start-page: 1481 year: 2014 ident: 154_CR150 publication-title: Brain doi: 10.1093/brain/awu020 – volume: 277 start-page: 1618 year: 2010 ident: 154_CR155 publication-title: FEBS J doi: 10.1111/j.1742-4658.2010.07588.x – volume: 24 start-page: 1717 year: 2015 ident: 154_CR121 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddu585 – volume: 305 start-page: 1292 year: 2004 ident: 154_CR73 publication-title: Science doi: 10.1126/science.1101738 – volume: 137 start-page: 1304 year: 2014 ident: 154_CR152 publication-title: Brain doi: 10.1093/brain/awu002 – volume: 26 start-page: 359 issue: 3 year: 2015 ident: 154_CR69 publication-title: Brain Pathol doi: 10.1111/bpa.12297 – volume: 12 start-page: 1129 year: 2009 ident: 154_CR87 publication-title: Nat Neurosci doi: 10.1038/nn.2372 – volume: 3 start-page: 13 year: 2013 ident: 154_CR86 publication-title: J Parkinsons Dis doi: 10.3233/JPD-120155 – volume: 6 start-page: e1901 year: 2015 ident: 154_CR79 publication-title: Cell Death Dis doi: 10.1038/cddis.2015.283 – volume: 165B start-page: 96 year: 2014 ident: 154_CR34 publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.32214 – volume: 103 start-page: 13813 year: 2006 ident: 154_CR156 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0605928103 – volume: 32 start-page: 2 issue: 1 year: 2012 ident: 154_CR24 publication-title: Mol Cell Biol doi: 10.1128/MCB.06159-11 – volume: 2 start-page: a009357 year: 2012 ident: 154_CR9 publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a009357 – volume: 31 start-page: 178 year: 2016 ident: 154_CR5 publication-title: Mov Disord doi: 10.1002/mds.26477 – volume: 441 start-page: 880 year: 2006 ident: 154_CR7 publication-title: Nature doi: 10.1038/nature04723 – volume: 32 start-page: 949 year: 2012 ident: 154_CR114 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2012-120178 – volume: 2012 start-page: 219625 year: 2012 ident: 154_CR15 publication-title: Int J Cell Biol doi: 10.1155/2012/219625 – volume: 30 start-page: 12535 year: 2010 ident: 154_CR50 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1920-10.2010 – volume: 122 start-page: 75 year: 2011 ident: 154_CR66 publication-title: Acta Neuropathol doi: 10.1007/s00401-011-0828-9 – volume: 170 start-page: 1101 year: 2005 ident: 154_CR88 publication-title: J Cell Biol doi: 10.1083/jcb.200504035 – volume: 22 start-page: 3315 year: 2013 ident: 154_CR122 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddt192 – volume: 125 start-page: 5259 year: 2012 ident: 154_CR124 publication-title: J Cell Sci doi: 10.1242/jcs.115865 – volume: 19 start-page: 983 year: 2013 ident: 154_CR8 publication-title: Nat Med doi: 10.1038/nm.3232 – volume: 4 start-page: 295 year: 2008 ident: 154_CR29 publication-title: Nat Chem Biol doi: 10.1038/nchembio.79 – volume: 3 start-page: 331 year: 2007 ident: 154_CR112 publication-title: Nat Chem Biol doi: 10.1038/nchembio883 – volume: 3 start-page: e332 year: 2013 ident: 154_CR116 publication-title: Transl Psychiatry doi: 10.1038/tp.2013.97 – volume: 44C start-page: 250 year: 2014 ident: 154_CR108 publication-title: Neurotoxicology doi: 10.1016/j.neuro.2014.07.006 – volume: 22 start-page: 1481 year: 2007 ident: 154_CR58 publication-title: Mov Disord doi: 10.1002/mds.21399 – volume: 12 start-page: 401 year: 2012 ident: 154_CR126 publication-title: Nat Rev Cancer doi: 10.1038/nrc3262 – volume: 16 start-page: 394 year: 2013 ident: 154_CR45 publication-title: Nat Neurosci doi: 10.1038/nn.3350 – volume: 110 start-page: 3537 year: 2013 ident: 154_CR146 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1220464110 – volume: 105 start-page: 1048 year: 2008 ident: 154_CR47 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2008.05217 – volume: 5 start-page: e9313 year: 2010 ident: 154_CR68 publication-title: Plos One doi: 10.1371/journal.pone.0009313 – volume: 10 start-page: e1004302 year: 2014 ident: 154_CR75 publication-title: Plos Genet doi: 10.1371/journal.pgen.1004302 – volume: 5 start-page: 28743 year: 2015 ident: 154_CR84 publication-title: Pathobiol Aging Age Relat Dis doi: 10.3402/pba.v5.28743 – volume: 67 start-page: 1464 year: 2010 ident: 154_CR53 publication-title: Arch Neurol doi: 10.1001/archneurol.2010.198 – volume: 199 start-page: 292 year: 2011 ident: 154_CR93 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.10.031 – volume: 12 start-page: 472 issue: 3 year: 2016 ident: 154_CR145 publication-title: Autophagy doi: 10.1080/15548627.2015.1136769 – volume: 31 start-page: 382 year: 2015 ident: 154_CR136 publication-title: Neurosci Bull doi: 10.1007/s12264-015-1528-y – volume: 272 start-page: 167 year: 2014 ident: 154_CR168 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.04.039 – volume: 33 start-page: 767 year: 2012 ident: 154_CR120 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2010.05.021 – volume: 30 start-page: 1639 issue: 12 year: 2015 ident: 154_CR54 publication-title: Mov Disord doi: 10.1002/mds.26141 – volume: 11 start-page: 709 year: 2012 ident: 154_CR11 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3802 – volume: 8 start-page: 98 year: 2012 ident: 154_CR141 publication-title: Autophagy doi: 10.4161/auto.8.1.18313 – volume: 2 start-page: ra36 year: 2009 ident: 154_CR85 publication-title: Sci Signal doi: 10.1126/scisignal.2000308 – volume: 4 start-page: e545 year: 2013 ident: 154_CR170 publication-title: Cell Death Dis doi: 10.1038/cddis.2013.73 – volume: 4 start-page: e5515 year: 2009 ident: 154_CR133 publication-title: Plos One doi: 10.1371/journal.pone.0005515 – volume: 53 start-page: 2258 issue: 4 year: 2015 ident: 154_CR109 publication-title: Mol Neurobiol doi: 10.1007/s12035-015-9173-7 – volume: 63 start-page: 165 year: 2014 ident: 154_CR67 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2013.11.007 – volume: 37 start-page: 2025 year: 2012 ident: 154_CR106 publication-title: Neurochem Res doi: 10.1007/s11064-012-0823-0 – volume: 66 start-page: 37 year: 2015 ident: 154_CR36 publication-title: Mol Cell Neurosci doi: 10.1016/j.mcn.2015.03.013 – volume: 35 start-page: 385 year: 2009 ident: 154_CR52 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2009.05.023 – volume: 136 start-page: 2130 year: 2013 ident: 154_CR163 publication-title: Brain doi: 10.1093/brain/awt131 – volume: 26 start-page: 1680 year: 2014 ident: 154_CR130 publication-title: Cell Signal doi: 10.1016/j.cellsig.2014.04.009 – volume: 124 start-page: 153 year: 2012 ident: 154_CR3 publication-title: Acta Neuropathol doi: 10.1007/s00401-012-1004-6 – volume: 18 start-page: 882 year: 2013 ident: 154_CR115 publication-title: Mol Psychiatry doi: 10.1038/mp.2012.115 – volume: 74 start-page: 337 year: 2013 ident: 154_CR117 publication-title: Ann Neurol doi: 10.1002/ana.24011 – volume: 1 start-page: 11 year: 2013 ident: 154_CR63 publication-title: Acta Neuropathol Commun doi: 10.1186/2051-5960-1-11 – ident: 154_CR132 doi: 10.1111/j.1460-9568.2007.05914.x – volume: 35 start-page: 873 year: 2013 ident: 154_CR35 publication-title: Neurol Res doi: 10.1179/1743132813Y.0000000224 – volume: 15 start-page: 1625 year: 2014 ident: 154_CR101 publication-title: Int J Mol Sci doi: 10.3390/ijms15011625 – volume: 368 start-page: 1845 year: 2013 ident: 154_CR23 publication-title: N Engl J Med doi: 10.1056/NEJMra1205406 – volume: 361 start-page: 1651 year: 2009 ident: 154_CR33 publication-title: N Engl J Med doi: 10.1056/NEJMoa0901281 – volume: 14 start-page: 70 year: 2004 ident: 154_CR14 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2003.12.002
SSID	ssj0047005
Score	2.5590851
SecondaryResourceType	review_article
Snippet	Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s... Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson's... AbstractConverging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in...
SourceID	hal proquest gale crossref springer
SourceType	Open Access Repository Aggregation Database Enrichment Source Index Database Publisher
StartPage	11
SubjectTerms	Autophagy (Cytology) Biomedical and Life Sciences Biomedicine Care and treatment Dosage and administration Genetic aspects Health aspects Life Sciences Molecular Medicine Neurology Neurosciences Parkinson's disease Rapamycin Review Risk factors
SummonAdditionalLinks	– databaseName: Springer Journals dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LahRBsDDRg5f4iJLRRFrwAcrgPPq1x0UMOYQgukhuTU9PdxIwsyGzG8jN38jv5UtS1duzZkUFPU91dU9NPbqmXgCvkE9ammyUV1JLdFBam494CLlUTjQqhMo3IQ6bUAcH-vBw9DnVcfdDtvsQkoyaOoq1lh96CrFRxgSlSgqe12twF62dpnkNX75-G9QvV8hXKXz522UrBiip4bVjyoK8dcX8JSoajc3ug_865kPYSHdLNl4wwyO447vHsDnu0K8-vWRvWMz2jL_RN2F_8rPwip1NZ5Q0hGungdk59RqwR5e5746pG0d3xCwVYPXspGNUJR0Lxq5_XPUshXeewGT30-TjXp4mK-SOK1XntbVN6bVqgi6LBvVh2QppveYNWv9W-JroGkppeeEKbj16PUJoGqJe84Bi-xTWu2nnt4CRx1Vp4X3lPK9dYdugdGtH1koZglAZFAO1jUtdx2n4xXcTvQ8tzYJgBglmiGCmzuDdcsnZouXG34Df0ic0JI6I19lUVYCno8ZWZsx1IYsROl4ZbK9Aohi5lcevkQmWG1LX7b3xPkKjJjg15HfKulIXJaIZ2MQkce8NHk1QiFHrDF4uH9MOlMLW-ek8wlCrIUSTwfuBdW6h-NMbPvsn6Odwv1rwXl6JbVifnc_9DtxzF7OT_vxFlJQbKjwM3w priority: 102 providerName: Springer Nature
Title	Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
URI	https://link.springer.com/article/10.1186/s13024-017-0154-3 https://www.proquest.com/docview/1865109988 https://www.proquest.com/docview/1862283463 https://inserm.hal.science/inserm-01446327
Volume	12
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1750-1326 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0047005 issn: 1750-1326 databaseCode: RBZ dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Open Access Full Text customDbUrl: eissn: 1750-1326 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0047005 issn: 1750-1326 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1750-1326 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0047005 issn: 1750-1326 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1750-1326 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0047005 issn: 1750-1326 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1750-1326 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0047005 issn: 1750-1326 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1750-1326 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0047005 issn: 1750-1326 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Journals customDbUrl: eissn: 1750-1326 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0047005 issn: 1750-1326 databaseCode: RSV dateStart: 20061201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3ZahsxUDRJH_rSKy3ZNDVb6AEtInvo2qfiloQEWmNSU9wnodVKSaBZO1k7kL_vjCw7caF56cuC2NGxO6OR5ibkLdBJg5WNaCGUAAGlMbRi3lMhLa-l94WrfSg2IQcDNR5Xw6hw66Jb5ZInBkbdTCzqyPdzJThacZT6PL2kWDUKrauxhMYG2cKy2UjncrwSuJgEEouWTOi-36GRDn0u0NmSM1qunUWRI2-coUPkndvmXwbScO4cPvnfFT8lj-ONM-0vSOQZeeDa52S734K0fXGTvk-DD2hQrm-T49FtOFY6nczQlQj6Tnxq5piBwJzeUNeeYY6O9jQ1GJbVpedtirHTIYysS6PF5wUZHR6Mvh7RWGyBWiZlSUtj6twpWXuVZzWwyLzhwjjFargQNNyVWaUynwvDMpsx40AQ4lxhXfWSedjJL8lmO2ndDklRCCsUd66wjpU2M42XqjGVMUJ4z2VCsuVf1zYmIsd6GL91EEiU0AtEaUCURkTpMiEfV12miywc9wF_QFRq3KEwrjUx0ABWh7mudJ-pTGQVyGIJ2VuDhJ1l116_A2JYTYiJuI_63wAamMOFRlFUlIW8zmGYJQHoyAE6fYv9hLxZvcYZ0KutdZN5gMHsQzBMQj4tyezOEP_6wt37J3xFHhULIqcF3yObs6u5e00e2uvZeXfVC1skPFWPbH05GAxPekETAa3h8ffhL2id_Pj5B2fbG-E
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGQIIXbgMRGGAkBhJTNCdxbOcBoQqYWq1UPPShb5bj2NsklpSlHeqP4j9yTi7disTe9sCz7_Hnzz45N0LeAk4KzGwUxkIJEFAKE2bc-1BIm-bS-9jlvkk2IScTNZtl37fI794XBs0qe05siLqoLP4jP4iUSFGLo9Sn-c8Qs0ahdrVPodHC4sitfoHIVn8cfYH93Yvjw6_Tz8OwyyoQWi5lEibG5JFTMvcqYjlwQVSkwjjFc7j5itQlLFPMR8JwZhk3Dl78aaowgXjCPcMkEcD4t4HGJcp6craW77gERHeKU5jtQY06QTTxQNvOlIfJxtXXXQC3TtD-8srj9i99bHPNHT74zz7QQ3K_e0_TQXsAHpEtVz4mO4PSLKqzFX1HGwvXRnWwQ0bTS2czOq8WaCgFbStPzRLjK5jjVejKE4xAUh5Tg05nNT0tKXqGN05yNe30WU_I9CbW9JRsl1XpnhGKImasUudi63himSm8VIXJjBHC-1QGhPWbrG0XZh2zffzQjbilhG5xoQEXGnGhk4B8WDeZtzFGrqv8HpGjkX-gX2s6NwqYHUby0gOumGAZSJoB2d2oCbxhN4r3AHvrATHM-HAwhtpAfWcaBW2RxPIigm56vOmO32p9CbaAvFkX4whos1e6atnUwdhK0E1A9ntUX-niXyt8fv2Ar8nd4fTbWI9Hk6MX5F7cnq8wTnfJ9uJ86V6SO_ZicVqfv2pOJyX6hsH-B_HUbfQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ra9RAEB9sFfGLrypGq67gA5TQPPaVj4d6VDyOgof027JJdtuCzR3NXaHf_Df89_xLnEk2Z09UED9n9pHJzOxOZuY3AM9RTmrqbBRnUkt0UGobF9z7WKpKlMr7zJW-azahplN9eFgchD6n7ZDtPoQk-5oGQmlqlnuL2vcqruVeS-E2yp6gtEnB43wLrnLKoyd3_dPnwRRzhTIWQpm_HbZxGAWTvHVMGZGXrpu_REi7g2d867-3fBtuhjsnG_VCcgeuuOYu7Iwa9LdPL9hL1mWBdr_Xd2Ay-1mQxRZzWgAllM09syvCILBHF7FrjgmlozlilgqzWnbSMKqe7grJvn_91rIQ9rkHs_H72dv9OHRciCuuVB7n1pap06r0Ok1KtJNpLaR1mpd4K6iFy5NCJz6VlidVwq1Db0gITc3Vc-5Rne_DdjNv3ANg5IllWjiXVY7nVWJrr3RtC2ul9F6oCJKB86YKaOTUFOOL6bwSLU3PMIMMM8Qwk0fwej1k0UNx_I34FX1OQ2qK81Y2VBvg7gjwyoy4TmRSoEMWwe4GJapXtfH4BQrEekFC494fTZAaLcSpIX9U5pk6T3GaQWRMMAOtwa0JCj1qHcGz9WNagVLbGjdfdTQEQYTTRPBmEKNLU_zpDR_-E_VTuH7wbmwmH6YfH8GNrBfDOBO7sL08W7nHcK06X560Z086BfoBMkEYpw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Therapeutic+potential+of+autophagy-enhancing+agents+in+Parkinsons+disease&rft.jtitle=Molecular+neurodegeneration&rft.au=Moors%2C+Tim+E&rft.au=Hoozemans%2C+Jeroen+J+M&rft.au=Ingrassia%2C+Angela&rft.au=Beccari%2C+Tommaso&rft.date=2017-01-25&rft.pub=Springer+Nature+B.V&rft.eissn=1750-1326&rft.volume=12&rft_id=info:doi/10.1186%2Fs13024-017-0154-3&rft.externalDocID=4312170641
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-1326&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-1326&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-1326&client=summon